INSTEM Stock

INS

GB00B3TQCK30

Days

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

News in other languages: INSTEM

23-08-30	Actualización de las fuertes variaciones del día: Instem, Stadler Rail, Aroundtown, Orsted, Brunello Cucinelli, Prudential, y otras
23-08-30	Les actions en mouvement : chaos au Gabon et plongeon au Danemark

More news

Managers and Directors: INSTEM

Manager	Title	Age	Since
Vik Krishnan CEO	Chief Executive Officer	-	2024-07-31
Joel Hooper COO	Chief Operating Officer	-	-
Vince D’Angelo CMP	Compliance Officer	-	-

Director	Title	Age	Since
David Gare CHM	Chairman	83	2010-10-20
Mike McGoun BRD	Director/Board Member	78	2010-10-21
Riaz Bandali BRD	Director/Board Member	57	2021-11-30

More insiders

Instem plc is a United Kingdom-based company that is a provider of information technology (IT) solutions to the global life sciences market. The Company operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trial Acceleration. Study Management Solutions offers software that enables organizations to collect, review, manage and report discovery and preclinical data. Regulatory Solutions provides software, outsourced services and consulting for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The Company's In Silico Solutions enable researchers to generate scientific insights through the identification, extraction and analysis of information. Clinical Trials Acceleration Solutions offers technology solutions and consulting services to facilitate data integration, statistics, analytics and insights for companies of any size or stage of clinical trial analysis.

Employees

510

Sector

More about the company

Apr. 19	Instem Limited Announces Termination of Director Appointment, Effective April 20, 2026	CI
Apr. 15	Instem Announces Appointment of Szczepan Baran as Chief Scientific Officer	CI
Mar. 19	Instem And U.S. Food And Drug Administration Extend Research Collaboration Agreement	CI
Feb. 25	Instem Limited Announces Termination of Jegan Thirukailayanathan as Director, Effective February 24, 2026 d	CI
Dec. 02	Instem Unveils New Global Headquarters in Boston, Massachusetts	CI
25-10-09	Instem Announces Enhanced Capabilities of Climb? Software for Non-GLP In Vivo Research	CI
25-07-31	Instem Limited acquired Xybion Digital Inc. from Banerjee Group LLC and others.	CI
25-07-28	Instem Limited acquired Rockstep Solutions, Inc.	CI
25-07-17	Instem Announces Provantis 12: A Powerful Step Forward in Preclinical Study Management	CI
25-06-18	Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-05-18	Instem Limited acquired Strong Tower Solutions, Inc.	CI
25-01-08	Instem Introduces Cloud-Hosted Non-Glp Pathology Module for Provantis	CI
24-12-26	Instem plc acquired Trimetra Limited.	CI

23-11-16	Instem : Issue of Equity, PDMR Dealings and Rule 2.9 Announcement	PU
23-11-15	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR
23-11-13	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR
23-11-10	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR
23-11-09	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR

Date	Insider	Type	Main position	Quantity	% Market Cap.
23-01-04	Philip Reason	Fiscal year	Chief Executive Officer	23,429	0.1032%
23-01-04	Nigel Goldsmith	Sell	Chief Financial Officer	15,000	0.0661%
23-01-04	Philip Reason	Sell	Chief Executive Officer	23,429	0.1032%

INSTEM Stock

Stocks

INS

GB00B3TQCK30

Latest news : INSTEM

Press Releases: INSTEM

News in other languages: INSTEM

Managers and Directors: INSTEM

Latest insider transactions

Company Profile